ESBATech AG: Clinical Trials

3 trials sponsored by ESBATech AG, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 12Completed 2

Follow ESBATech AG: new trials by email

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Exploratory Study on Topical ESBA105 in Acute Anterior Uveitis
ESBA105 - Anterior Uveitis
Phase 2CompletedESBATech AG92009-01-012011-05-26
Ocular Biodistribution Study for Topically Applied ESBA105
Placebo - Cataract
Phase 1 / Phase 2CompletedESBATech AG792009-01-012010-09-24
Study of Intra-articular DLX105 Applied to Patients With Severely Painful Osteoarthritis of the Knee
DLX105, a single-chain (scFv) antibody fragment against TNF-alpha, Placebo - Osteoarthritis
Phase 1 / Phase 2CompletedESBATech AG272008-12-012010-09-24

Conditions studied

Cataract (1)  ·  Macular Edema (1)  ·  Osteoarthritis (1)  ·  Pain (1)  ·  Uveitis (1)  ·  Uveitis, Anterior (1)

Interventions

ESBA105 (1)

Countries

Germany (2)  ·  Switzerland (2)

Top investigators

Manfred Zierhut, MD (1)  ·  Michael A Thiel, MD, PhD (1)  ·  PD.Dr. Diego Kyburz, MD (1)  ·  Prof. Georg Schett, MD (1)